Literature DB >> 21677176

A switch in the neuromodulatory effects of dopamine in the oval bed nucleus of the stria terminalis associated with cocaine self-administration in rats.

Michal Krawczyk1, Robyn Sharma, Xenos Mason, Julian Debacker, Andrea A Jones, Eric C Dumont.   

Abstract

Chronic exposure to drugs of abuse alters brain reward circuits and produces functional changes in the dopamine (DA) system. However, it is not known whether these changes are directly related to drug-driven behaviors or whether they simply are adaptive responses to long-term drug exposure. Here, we combined the rat model of cocaine self-administration with brain slice electrophysiology to identify drug-use related alterations in the neuromodulatory effects of DA in the oval bed nucleus of the stria terminalis (ovBST), a robust DA terminal field. Long-Evans rats self-administered cocaine intravenously (0.75 mg/kg/injection) for an average of 15 d, on reward-lean or -rich schedules of reinforcement. Brain slice recordings conducted 20 h after the last self-administration session revealed a reversal of the neuromodulatory effect of DA on GABA(A)-IPSCs. Specifically, the effect of DA switched from a D2-mediated decrease in drug-naive rats to a D1-receptor-mediated increase in GABA(A)-IPSC in cocaine self-administering rats. Furthermore, the switch in DA modulation of GABA(A)-IPSC remained after a 30 d withdrawal period. In contrast, this switch was not observed after the acquisition phase of cocaine self-administration, when rats received cocaine passively, or in rats maintaining sucrose self-administration. Therefore, our study reveals a reversal in the effects of DA on inhibitory transmission, from reduction to enhancement, in the ovBST of cocaine self-administering rats. This change was unique to voluntary intake of cocaine and maintained after a withdrawal period, suggesting a mechanism underlying the maintenance of cocaine self-administration and perhaps craving during drug-free periods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677176      PMCID: PMC4011826          DOI: 10.1523/JNEUROSCI.0377-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens.

Authors:  S M Nicola; J Surmeier; R C Malenka
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

2.  Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration.

Authors:  Drake Morgan; Kathleen A Grant; H Donald Gage; Robert H Mach; Jay R Kaplan; Osric Prioleau; Susan H Nader; Nancy Buchheimer; Richard L Ehrenkaufer; Michael A Nader
Journal:  Nat Neurosci       Date:  2002-02       Impact factor: 24.884

Review 3.  Topography of projections from amygdala to bed nuclei of the stria terminalis.

Authors:  H W Dong; G D Petrovich; L W Swanson
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure.

Authors:  Michael A Nader; James B Daunais; Tonya Moore; Susan H Nader; Rodney J Moore; Hilary R Smith; David P Friedman; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

5.  Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

Authors:  E Nann-Vernotica; E C Donny; G E Bigelow; S L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

6.  Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain.

Authors:  H W Dong; G D Petrovich; A G Watts; L W Swanson
Journal:  J Comp Neurol       Date:  2001-08-06       Impact factor: 3.215

7.  Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis.

Authors:  Michal Krawczyk; François Georges; Robyn Sharma; Xenos Mason; Amandine Berthet; Erwan Bézard; Eric C Dumont
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

8.  A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats.

Authors:  S Erb; N Salmaso; D Rodaros; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  2001-01-19       Impact factor: 4.530

9.  D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

Authors:  Charles R Gerfen; Shigehiro Miyachi; Ronald Paletzki; Pierre Brown
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

10.  Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala.

Authors:  Francesco Leri; Joseph Flores; Demetra Rodaros; Jane Stewart
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  23 in total

1.  Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala.

Authors:  D De Bundel; C Zussy; J Espallergues; C R Gerfen; J-A Girault; E Valjent
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

2.  D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.

Authors:  Michal Krawczyk; Xenos Mason; Julian DeBacker; Robyn Sharma; Catherine P Normandeau; Emily R Hawken; Cynthia Di Prospero; Cindy Chiang; Audrey Martinez; Andrea A Jones; Évelyne Doudnikoff; Stephanie Caille; Erwan Bézard; François Georges; Éric C Dumont
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

3.  Contrasting distribution of physiological cell types in different regions of the bed nucleus of the stria terminalis.

Authors:  Olga E Rodríguez-Sierra; Hjalmar K Turesson; Denis Pare
Journal:  J Neurophysiol       Date:  2013-08-07       Impact factor: 2.714

4.  Synaptic Plasticity in the Bed Nucleus of the Stria Terminalis: Underlying Mechanisms and Potential Ramifications for Reinstatement of Drug- and Alcohol-Seeking Behaviors.

Authors:  Nicholas A Harris; Danny G Winder
Journal:  ACS Chem Neurosci       Date:  2018-06-13       Impact factor: 4.418

Review 5.  Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis.

Authors:  Sarah E Daniel; Donald G Rainnie
Journal:  Neuropsychopharmacology       Date:  2015-06-22       Impact factor: 7.853

Review 6.  The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse.

Authors:  Thomas Louis Kash
Journal:  Alcohol       Date:  2012-03-25       Impact factor: 2.405

7.  Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference.

Authors:  Gregory C Sartor; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

8.  A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis.

Authors:  E R Hawken; C P Normandeau; J Gardner Gregory; B Cécyre; J-F Bouchard; K Mackie; É C Dumont
Journal:  Neuropsychopharmacology       Date:  2019-01-07       Impact factor: 7.853

9.  PACAP in the BNST produces anorexia and weight loss in male and female rats.

Authors:  Margaret Kocho-Schellenberg; Kimberly R Lezak; Olivia M Harris; Erin Roelke; Niklas Gick; Inyop Choi; Shaquille Edwards; Emily Wasserman; Donna J Toufexis; Karen M Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2014-01-17       Impact factor: 7.853

10.  GluN2B-containing NMDA receptors blockade rescues bidirectional synaptic plasticity in the bed nucleus of the stria terminalis of cocaine self-administering rats.

Authors:  Julian deBacker; Emily R Hawken; Catherine P Normandeau; Andrea A Jones; Cynthia Di Prospero; Elysia Mechefske; James Gardner Gregory; Scott J Hayton; Éric C Dumont
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.